FI20135172A - Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation - Google Patents
Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation Download PDFInfo
- Publication number
- FI20135172A FI20135172A FI20135172A FI20135172A FI20135172A FI 20135172 A FI20135172 A FI 20135172A FI 20135172 A FI20135172 A FI 20135172A FI 20135172 A FI20135172 A FI 20135172A FI 20135172 A FI20135172 A FI 20135172A
- Authority
- FI
- Finland
- Prior art keywords
- lace
- inhibiting
- controlling
- scar formation
- nanofibrillar polysaccharide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20135172A FI126109B (en) | 2013-02-22 | 2013-02-22 | Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation |
CA2897514A CA2897514C (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
US14/767,857 US9833540B2 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
ES14708926.2T ES2614908T3 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scar formation |
DK14708926.2T DK2958599T3 (en) | 2013-02-22 | 2014-02-21 | NANOFIBRILLARY POLYSACCHARIDE USED BY CONTROL AND PREVENTION OF CONTRACTION AND CREATION |
EP14708926.2A EP2958599B1 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
PCT/FI2014/050131 WO2014128354A1 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20135172A FI126109B (en) | 2013-02-22 | 2013-02-22 | Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20135172A true FI20135172A (en) | 2014-08-23 |
FI126109B FI126109B (en) | 2016-06-30 |
Family
ID=50239668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20135172A FI126109B (en) | 2013-02-22 | 2013-02-22 | Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation |
Country Status (7)
Country | Link |
---|---|
US (1) | US9833540B2 (en) |
EP (1) | EP2958599B1 (en) |
CA (1) | CA2897514C (en) |
DK (1) | DK2958599T3 (en) |
ES (1) | ES2614908T3 (en) |
FI (1) | FI126109B (en) |
WO (1) | WO2014128354A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109310797A (en) * | 2016-04-06 | 2019-02-05 | 芬欧汇川集团 | The method and medical product of medical product of the preparation comprising nanometer fibril cellulose |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI127526B (en) * | 2012-11-03 | 2018-08-15 | Upm Kymmene Corp | Method for producing nanofibrillar cellulose |
FI129421B (en) | 2014-03-12 | 2022-02-15 | Maelkki Yrjoe | Production and use of nanocellulose and its precursors |
BR112016028230B1 (en) * | 2014-05-30 | 2022-05-17 | Borregaard As | Microfibrillated cellulose and gel-like dispersion of microfibrillated cellulose |
FI126398B (en) | 2014-12-18 | 2016-11-15 | Upm Kymmene Corp | Method for chemical testing |
FI125884B2 (en) | 2014-12-22 | 2019-03-29 | Upm Kymmene Corp | Treating nanofibrillar cellulose hydrogel at eleveted temperature |
FI125882B (en) | 2014-12-22 | 2016-03-31 | Upm Kymmene Corp | Heat treatment of nanofibril cellulose hydrogel |
FI126120B (en) * | 2014-12-22 | 2016-06-30 | Upm Kymmene Corp | Process for the production of oxidized nanofibril cellulose hydrogel |
EP3268051A4 (en) * | 2015-03-13 | 2018-08-15 | Joslin Diabetes Center, Inc. | Methods to accelerate wound healing in diabetic subjects |
FI127834B (en) | 2015-06-04 | 2019-03-29 | Upm Kymmene Corp | Process for producing a nanofibrillar cellulose hydrogel |
ES2706489T3 (en) * | 2015-12-31 | 2019-03-29 | Upm Kymmene Corp | A multi-layer medical product comprising nanofibrillary cellulose and a preparation method thereof |
EP3335740A1 (en) | 2016-12-15 | 2018-06-20 | UPM-Kymmene Corporation | Medical hydrogel |
DE102017010930A1 (en) | 2017-11-25 | 2019-05-29 | Dr. 3 Entwicklungsgesellschaft mbH i. Gr. | Topical preparations |
SI3533458T1 (en) * | 2018-03-02 | 2023-09-29 | Upm-Kymmene Corporation | A medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof |
TWI693929B (en) * | 2018-06-27 | 2020-05-21 | 南六企業股份有限公司 | Antibacterial wound dressing |
EP3987011A1 (en) * | 2019-06-24 | 2022-04-27 | UPM-Kymmene Corporation | Transplantable cell composition comprising eukaryotic cells in a nanofibrillar cellulose hydrogel, method for preparing thereof and use of nanofibrillar cellulose |
KR102344588B1 (en) * | 2019-06-25 | 2021-12-30 | 네이처코스텍 주식회사 | Composition for dermal filler containing denatured cellulose |
EP3991761A4 (en) * | 2019-06-26 | 2023-01-11 | Nature Costech Co., Ltd. | Dermal filler composition comprising modified cellulose |
US20220305170A1 (en) | 2019-07-05 | 2022-09-29 | OJl HOLDINGS CORPORATION | Wound-covering material and production method therefor |
EP3771470A1 (en) * | 2019-07-29 | 2021-02-03 | UPM-Kymmene Corporation | Medical hydrogel comprising nanofibrillar cellulose, tailored wound dressing, and methods for preparing thereof |
KR102497989B1 (en) * | 2019-09-02 | 2023-02-10 | 주식회사 에이엔폴리 | Hemostatic dressings |
EP3791858A1 (en) * | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Injectable pharmaceutical formulation |
EP3791864A1 (en) | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Method for preparing pharmaceutical composition and pharmaceutical composition |
EP3816338A1 (en) * | 2019-10-31 | 2021-05-05 | UPM-Kymmene Corporation | Medical product and method for preparing thereof |
KR102391943B1 (en) * | 2019-11-26 | 2022-04-29 | 네이처코스텍 주식회사 | Composition for dermal filler containing denatured cellulose and hyaluronic acid |
US20240091399A1 (en) * | 2022-09-09 | 2024-03-21 | Upm-Kymmene Corporation | Medical grade nanofibrillar cellulose hydrogel, a method for treating a subject in need of treatment of body with implantable material and a method for manufacturing the medical grade nanofibrillar cellulose hydrogel |
EP4335467A1 (en) * | 2022-09-09 | 2024-03-13 | UPM-Kymmene Corporation | A medical grade nanofibrillar cellulose hydrogel for use as implantable material |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3783073T2 (en) | 1986-04-22 | 1993-04-29 | Ajinomoto Kk | MODIFIED CELLULOSE GEL MADE BY MICROORGANISMS AND ITS COMPLEX WITH ANIMAL CELLS. |
US8951551B2 (en) | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
BRPI0601330A (en) | 2006-03-31 | 2007-12-04 | Wellborn Participacoes Societa | topical composition of biocellulose in gel form, spray aerosol, cream and or aqueous suspension for treatment of epithelial lesions |
WO2008010199A2 (en) * | 2006-07-18 | 2008-01-24 | Nanopeutics S.R.O. | A nanofibre product |
US9180166B2 (en) * | 2010-03-12 | 2015-11-10 | New Jersey Institute Of Technology | Cartilage repair systems and applications utilizing a glycosaminoglycan mimic |
ES2471367T3 (en) | 2010-07-30 | 2014-06-26 | Institut Quimic De Sarria | Bioactive implant |
FI123988B (en) | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Cell Culture Materials |
WO2012106707A2 (en) * | 2011-02-04 | 2012-08-09 | Bc Genesis Llc | Biosynthetic functional cellulose (bc) fibers as surgical sutures and reinforcement of implants and growing tissue |
FI126259B (en) | 2011-02-11 | 2016-09-15 | Upm Kymmene Corp | Microfibrillated cellulose for use in the treatment of atopic dermatitis and psoriasis |
US9211256B2 (en) | 2011-03-08 | 2015-12-15 | The Johns Hopkins University | Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof |
-
2013
- 2013-02-22 FI FI20135172A patent/FI126109B/en active IP Right Grant
-
2014
- 2014-02-21 EP EP14708926.2A patent/EP2958599B1/en active Active
- 2014-02-21 ES ES14708926.2T patent/ES2614908T3/en active Active
- 2014-02-21 DK DK14708926.2T patent/DK2958599T3/en active
- 2014-02-21 US US14/767,857 patent/US9833540B2/en active Active
- 2014-02-21 WO PCT/FI2014/050131 patent/WO2014128354A1/en active Application Filing
- 2014-02-21 CA CA2897514A patent/CA2897514C/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109310797A (en) * | 2016-04-06 | 2019-02-05 | 芬欧汇川集团 | The method and medical product of medical product of the preparation comprising nanometer fibril cellulose |
Also Published As
Publication number | Publication date |
---|---|
ES2614908T3 (en) | 2017-06-02 |
EP2958599B1 (en) | 2016-11-16 |
CA2897514C (en) | 2021-10-26 |
CA2897514A1 (en) | 2014-08-28 |
US20150367024A1 (en) | 2015-12-24 |
DK2958599T3 (en) | 2017-02-20 |
WO2014128354A1 (en) | 2014-08-28 |
US9833540B2 (en) | 2017-12-05 |
EP2958599A1 (en) | 2015-12-30 |
FI126109B (en) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20135172A (en) | Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation | |
IL267681A (en) | Selective grp94 inhibitors and uses thereof | |
HK1220540A1 (en) | Controlling stability in anr devices anr | |
BR112016008141A2 (en) | ARTICLE | |
BR302014001891S1 (en) | Dressing applied ornamental setting | |
FI20135842L (en) | Method and system for treating lignin | |
CL2015002146A1 (en) | Compositions and procedures for treating superficial wounds | |
AP2015008844A0 (en) | Heteroaromatic compounds and their use as dopamined1 ligands | |
IL244118A0 (en) | Compositions and methods for treating chronic urticaria | |
BR302014001956S1 (en) | Grinding ornamental setting | |
PL2994577T3 (en) | Self-actuating flood guard | |
FI20135341A (en) | Process for the production of biofuel and the use of biofuel | |
CL2015003620A1 (en) | Compositions for postharvest treatment and related methods | |
FI20136192A (en) | Dishwashers and vessels | |
RS56108B1 (en) | Form dressing roller | |
DE112014005265A5 (en) | Ice mat | |
DK2948116T3 (en) | Wound dressing | |
HK1219893A1 (en) | Compound and methods for treating long qt syndrome qt | |
DK3021877T3 (en) | Wound dressing | |
HRP20170877T1 (en) | Polysaccharide for use in preventing metastasis formation and/or relapse | |
ES1079169Y (en) | PAJAMA FOR PEOPLE WITH PSYCHICAL DECREASE | |
TH1401006451B (en) | Delivery leaf and spraying machine | |
ZA201408732B (en) | Composition and methods for treating wounds | |
FI10292U1 (en) | Insert for floor well and floor well | |
TH1401006308A (en) | Plant controls and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 126109 Country of ref document: FI Kind code of ref document: B |